Technology Transfer from the University of Oxford An Introduction to Isis, Technology Transfer, and...
-
Upload
kayla-wood -
Category
Documents
-
view
215 -
download
0
Transcript of Technology Transfer from the University of Oxford An Introduction to Isis, Technology Transfer, and...
Technology Transfer from the University of Oxford
An Introduction to Isis, Technology Transfer, and
Technology Transfer Consulting
WIPO 11th September 2008 Cardiff
Dr Roger Welch
Isis Innovation
> A company owned by the University of Oxford> To help researchers commercialise the results of their
research
Activities Patenting 50 p.a.
Licensing of intellectual property 30 p.a.
Consulting and service contracts 50 p.a.
Formation of new companies 8 p.a.
Isis Innovation Ltd
Oxford Technology TransferIP, Patents, Licences, Spin-outs, Material Sales, Seed Funds, Isis Angels Network
Oxford ExpertiseConsulting, Services
Isis Consulting Business Technology Transfer and Innovation Management
A company 100% owned by the University of Oxford
Isis Innovation Staff
Oxford University Consulting (6)Head of Group
Steve LeeProject Managers Dr Caroline Jenkins
Andrew GoffGurinder Punn
Gill RoweAdministratorKerry Antcliffe
Project Manager Teams
Dr Mairi Gibbs
Dr David Churchman Dr Emma Sceats
Dr Stuart Wilkinson
Dr Colin Story
Dr David PhillipsDr Weng Sie Wong
Dr Dina ChenYa-hsin Shen
Patent & Licence Administration
ManagerSteven Bayliss
Post-Deal AdminRidi Faruque
Patent Administrator
tba
Technology Transfer Group (25)
Head of GroupLinda Naylor
Project Manager Teams
Dr David Eastham
Dr Jamie Ferguson Dr Rakesh Roshan
Dr Mike Gilbert
Dr Adam Stoten
Dr Fiona BeggDr Sarah Deakin
Dr Christine WhyteDr John Wilson
Dr Cynthia GreenDr Erica Conway
IAN & Seed Fund Co-ordinatorAndrea Alunni
Isis Enterprise (10)Head of Group
Dr David BaghurstGeneral ManagerDr Mark MawhinneyProject Managers
Dr Sarah MacnaughtonTerry Pollard
Robert SwerdlowDr Roger WelchDr Paul WhyteDr Suzy WoodDr Tim Hart
AdministratorOlivia Thomas
Staff: 56 PhD’s: 28 MBA’s: 12
Managing DirectorTom Hockaday
Business Support (7)Head of Group
Matt SimonsAccounts
Gemma AllnuttMarketing
Renate Krelle Cynthia Warmington
LegalEmma WheatleySarah Litchfield
Central Admin (5)Office Manager
Jenny BaileyOffice Administrator
Nelson SaHR Assistant
Alex AllanFacilitiesJane TarryReceptionGillian Hicks
OSEM (2)Dr Chris TowlerJames Mallinson
Year Ending March
2000 2001 2002 2003 2004 2005 2006 2007 2008
University Investment
£1m £1m £1m £1m £1m £1.2m £1.2m £1.2m £1.2m
Staff 17 21 23 34 36 36 36 37 44
Open Projects 319 415 476 629 725 764 784 841 978
Patents filed 55 63 82 65 52 55 57 49 68
Licence Deals 21 36 42 37 31 38 45 50 74
Consultancy 34 50 48 59 89 102
Spin-outs 6 8 8 7 3 4 6 7 4
Isis Innovation 2000 - 2008
Who profits from Technology Transfer ?
> Researchers> Technology, royalties and company shares
> Industry > New Technology
> University> Royalties, shares
> Research Funding > from spinouts and licensees
> Economy> New industry and technology to existing ones
> Investors> High returns on world class science
Oxford Model - Key Ingredients
> Rich portfolio of wholly-owned IPR> Strong, world-class research base
> Diverse research sponsorship (700)
> Clear intellectual property (IP) policy > Led from the top and widely supported
> Investment in research support & tech transfer> 85 staff in Research Services and Isis Innovation
> Clear internal demarcation of responsibility
> Effective internal & external communications
Intellectual Property Policy (October 2000)
> University claims ownership of all employees’ and students’ IP
rights resulting from University research activities
> The university assists those researchers who wish to
commercialise their research
> by patenting, licences, spinout companies & consultancy
> Researchers share the benefits
> Royalty shares from licences
> Equity in spinout companies
> Income from personal consultancy
Licensing
> Licensing is when you give someone permission to use your invention in return for:
> money up front or > money when they achieve a defined event or > a share of their sales or > a share of their profits or> A combination of some or all of the above
Royalty Rates
> Tables are available but > With new technology the rate is rarely defined
> One rule of thumb:“We want a third of your incremental gross profit”
> So if they make 30% gross on sales we want 10% of sales> They do the work so they get 70%> Without our idea they don’t get anything
Licensing
Pro> They work you get paid> Can make big money> Stimulates research ideas
Con> Needs patent protection> Long time coming> Relies on licensee> May need proof of concept
(resources)> They could bury it
Spinouts
Pro> Most fun> You can make most money> You still retain some control
Con> Needs IP protection> Needs Investment> Needs management> Needs a lot of your time> Needs a lot of external advice
> Management> Lawyers> Etc.
Investors
> Investors want their money back
> They want more than they put in
> They want to know by when
> They want to know how certain
Investment SourcesInvestment Sources
Oxford University Challenge Seed Fund £4m> Launched in 1999 University £1m Treasury, Wellcome, Gatsby £3m> Development projects, spin-out seed equity; in a total of 83 projects> £4m investment has resulted in Equity stakes in 22 spin-outs, 7
completed licensing deals & 33 active technology projects> These 22 spin-outs have attracted £40m seed/venture investment
Isis Angels Network > Business Angels> Seed / Venture Capital> Private Equity> 100 Members> Events> No Charges
Oxford Spin-outs (pre 2000)
1959 Oxford Instruments *
1977 Oxford Lasers
1988 Oxford Glycosciences *
1989 Oxford Molecular *
1992 Oxford Asymmetry *
1994 PowderJect *
1995 Oxford Gene Technology
1996 Oxford Biomedica *
1997 Oxagen
1998 5 Opsys, Synaptica, Prolysis, Celoxica * , Sense Therapeutic
1999 6 Medigene(Avidex) * , Oxxon Pharmaccines, Dash, Oxonica * , AuC Sensing, OMIA
* stock exchange listing
Oxford Spin-outs (post 2000)
Total external investment to date in spin-outs Post 1997: £334m £34m Seed/Business Angels &£300m Venture/Institution Capital * stock exchange listing
2000 7Third Phase, Mindweavers, Oxford BioSignals, Oxford BioSensors, TolerRx, OXIVA, Pharma DM
2001 7OxLoc, Oxford Bee Co, Oxford Ancestors, Novarc, Oxford ArchDigital, Natural Motion, Inhibox
2002 9Pharminox, Minervation, Spinox, Zyentia, Oxitec, Oxford Immunotec, ORRA, GlycoForm, BioAnalab
2003 4 VASTOx * , ReOx, Riotech, OCSI
2004 4 Avacta(OMD) * , G-Nostics, Surface Therapeutics, EKB Technology
2005 5Oxford Nanolabs, Oxford RF Sensors, Oxbridge Pulsars, Celleron, Oxford Catalysts *
2006 7TDeltaS, Oxford Medistress, Particle Therapeutic, Aurox, Oxford Advanced Surfaces * , Cytox, OxTox
2007 4 Eykona Technologies, Clinox, Oxford Biodynamics, Crysalin
2008 [2] Semmle, Oxford-Emergent TB Consortium,
Begbroke Science & Business Park
University Department of Materials
Prolysis
Oxford Gene Technology
OxLoc
Oxonica
> Owned & operated by Oxford University> University research labs> Business Incubator & premises for new companies> Central meeting room and café
Centre for Innovation & Enterprise
> Isis Enterprise offers consulting expertise and advice in technology transfer, based upon the success of Isis Innovation as Oxford University’s technology transfer company.
> Isis Enterprise clients and services:> Governments:
policy and benchmarking studies
> Universities and research institutes: policy studies, technology audit, technology transfer office
partnerships, training and secondment programmes
> Companies: out-licensing or in-licensing support, university relationship
managementopen innovation partnerships
> Professional services firms: market validation studies
> Investors: investor readiness appraisal
> www.isis-enterprise.com
Isis Enterprise
> In December 2006, Isis became a Low Carbon Incubator in partnership with The Carbon Trust.
> Isis offers support for early stage low carbon projects to anyone in the UK involved in developing low carbon technologies with commercial potential.
> We work with: > Individuals> Companies> Universities> Research Institutes
Isis and The Carbon Trust
Sep 08
www.isis-innovation.com
Executive(policies)
Other academics
Gene pool Commercially
active scientists
The University
Tech transfer
office
StudentsBrokers
Itinerant managers Consultants
Sub-culture in a barter economy
VC’s Lawyers
Headhunters
PR agents
Realestate
LeasingBanks
Accountants
Specialist suppliers
Otherstart-ups
Contacts
Isis Innovation LtdEwert HouseEwert PlaceSummertown Oxford OX2 7SG
T 01865 280830F 01865 280831E [email protected] www.isis-innovation.com
Register to receive Isis E-News at www.isis-innovation.com/news/enews